China's liver cancer cases to hit 264,000 by 2034
A new report projects that China will account for 71% of liver cancer cases across eight major global markets by 2034. While hepatitis rates are declining due to vaccinations, rising obesity and alcohol consumption are contributing to the upward trend.
Why it matters
The data highlights a significant public health challenge in China and the shifting causes of liver cancer globally.
Published: 54 minutes ago Photo by Marek Piwnicki via Pexels China's liver cancer cases to hit 264,000 by 2034 It will account for roughly 71% of the projected 8MM incident cases.
China will carry the heaviest burden of hepatocellular carcinoma (HCC) amongst the world's eight major markets (8MM) by 2034, reaching 264,000 diagnosed incident cases that year.
According to GlobalData, this distribution is similar for five-year diagnosed prevalent cases of HCC, where China will also have the highest number, with 702,000 cases.
The report noted that China alone will account for roughly 71% of projected 8MM incident cases and about 77% of five-year prevalent cases by 2034.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in